Treasury Yields Dip Slightly as Iran Peace Deal Optimism Tempers Market Sentiment CBSE Exam Portal Glitches and Hack Claims Prompt Government Investigation US Consumer Sentiment Remains Pessimistic Amid Inflation and Trade Policy Concerns Supermarket Price Cap Debate Exposes Fragility of UK Food System Amid Global Pressures Kevin Warsh to Be Sworn In as Federal Reserve Chair on Friday Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut Stock Surges Xponential Fitness Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction VOYG Q1 2026 Earnings EPS Misses Estimates but Stock Surges 11 on Investor Optimism Chubb Limited Q1 2026 Earnings EPS Beat Amidst Mixed Market Sentiment Katapult Holdings Q1 2026 Earnings Massive Profitability Surprise Drives DoubleDigit EPS Beat Clover Health Q1 2026 Earnings EPS Surges 12876 Above Estimates Stock Reaction Muted SYF Q1 2026 Earnings EPS Beat Highlights Resilient Consumer Credit Performance US Global Investors GROW Edges Lower as Stock Nears Key Support Zone MGRB Shows Modest Uptick as FixedIncome Security Holds Near Midpoint of Range MFS High Income Municipal Trust CXE Edges Higher Amid Steady Income Demand Grid Dynamics Holdings GDYN Edges Higher Near Resistance Level RingCentral RNG Surges 313 as Shares Approach Key Resistance Guzman y Gomez Shares Surge on Decision to Exit US Market and Refocus on Australia JCAP Q1 2026 Earnings EPS Surprise Lifts Expectations Amid Narrow Revenue Disclosures Lakeshore Acquisition III Corp Rights LCCCR Trading at Support as Momentum Remains Flat CB Q1 2026 Earnings Solid EPS Beat Amid Premium Growth and Underwriting Discipline JLL Q1 2026 Earnings EPS Surges Past Estimates Amid Resilient Real Estate Services CIFR Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Uncertainty DCH Q1 2026 Earnings Massive EPS Surprise Propels Stock Higher Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech PLMR Q1 2026 Earnings EPS Surpasses Estimates by 3 Despite Slight Stock Decline Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats